Cellular and Molecular Life Sciences
January 21, 2025
Alejandra Pulido-Saavedra, Henrique Nunes Pereira Oliva, Tiago Paiva Prudente et al.
5 citations
The current opioid crisis has had an unprecedented public health impact. Approved medications for opioid use disorder (OUD) exist, yet their limitations indicate a need for innovative treatments. Limited preliminary clinical studies suggest specific psychedelics might aid OUD treatment, though most clinical evidence remains observational, with few controlled trials. This review aims to bridge...
Cellular and Molecular Life Sciences
September 10, 2024
Klemens Egger, Helena Aicher, Paul Cumming et al.
30 citations
The potent hallucinogen N,N-dimethyltryptamine (DMT) has garnered significant interest in recent years due to its profound effects on consciousness and its therapeutic psychopotential. DMT is an integral (but not exclusive) psychoactive alkaloid in the Amazonian plant-based brew ayahuasca, in which admixture of several β-carboline monoamine oxidase A (MAO-A) inhibitors potentiate the activity...
Cellular and Molecular Life Sciences
February 27, 2024
Radhika Rawat, Elif Tunc-Ozcan, Sara Dunlop et al.
17 citations
Administration of multiple subanesthetic doses of ketamine increases the duration of antidepressant effects relative to a single ketamine dose, but the mechanisms mediating this sustained effect are unclear. Here, we demonstrate that ketamine's rapid and sustained effects on affective behavior are mediated by separate and temporally distinct mechanisms. The rapid effects of a single dose of...
Cellular and Molecular Life Sciences
April 1, 2016
Jian Xu, Pradeep Kurup, Tyler D Baguley et al.
Brain-derived neurotrophic factor (BDNF) and STriatal-Enriched protein tyrosine Phosphatase 61 (STEP61) have opposing functions in the brain, with BDNF supporting and STEP61 opposing synaptic strengthening. BDNF and STEP61 also exhibit an inverse pattern of expression in a number of brain disorders, including schizophrenia (SZ). NMDAR antagonists such as phencyclidine (PCP) elicit SZ-like...
Cellular and Molecular Life Sciences
May 1, 2007
A Rosa, D Poyares, W Moraes et al.
This review presents traditional and cutting-edge interventions in sleep research, including descriptions of the relationship of rapid eye movement-non-rapid eye movement sleep with the autonomous nervous system, and dream research methodology. Although sleep and dreaming are overlapping and non- separable phenomena, they are not typically addressed simultaneously in the scientific sleep...
Cellular and Molecular Life Sciences
February 1, 1988
A. David Smith, David P. Geaney, Michael Schächter et al.
15 citations
Chronic treatment with phenothiazines and thioxanthenes has been found to enhance 5-HT-induced aggregation of human platelets. A method has been developed to study 5-HT2 receptor binding sites on platelets utilising [3H]-LSD and more recently 125I/LSD. Results are presented which suggest that the LSD binding site is indeed the 5-HT2 binding site and that the LSD binding characterises the...
Cellular and Molecular Life Sciences
March 1, 1978
Greg Went
43 citations
Using the micronucleus test as a screening method for mutagenic activity, no significant increase in the number of micronuclei was found when LSD, psilocybin or delta 9-THC were administered in 3 logarithmically increasing doses to mice, Azathioiprine (Imuran), given as a positive control, caused a statistically significantt increase in the micronucleated cells.
Cellular and Molecular Life Sciences
November 1, 1976
E. A. Zeller, Gregory S. Couper, Shankar V. Huprikar et al.
1 citation
The pharmacological action of mescaline on goldfish was studied with the Bitterman-Agranoff shock-avoidance test. In short term experiments with high mescaline doses an increase in learning rates was observed. Similar results were obtained with apomorphine and L-dopa. However, when the fish were exposed to smaller mescaline doses (or to fluphenazine) for 3 days, their ability to avoid electric...